Ovarian Cancer
FDA Approvals, News & UpdatesOvarian Cancer
Women with advanced ovarian cancer now have a new once-daily treatment option. In April 2020, the Food and Drug Administration (FDA) approved Zejula (niraparib) for the maintenance treatment of all women with advanced ovarian cancer (including epithelial cancer, fallopian tube cancer, and primary peritoneal cancer) who have responded well to first-line chemotherapy. Maintenance therapy is the treatment of cancer with medication, typically following a first round of treatment (in this case, platinum-based chemotherapy).
Ovarian Cancer
Here are the drugs and financial support services available to patients receiving treatment for Ovarian Cancer.
Ovarian CancerSurvivorship
Diagnosed with ovarian cancer at age 3, Tiffany R. Easley learned the power of owning one’s story, detailing her powerful “SOAR” survivor mindset.
Ovarian CancerSurvivorship
Annette McElhiney, PhD, notes the psychosocial needs of patients with cancer, survivors, and caregivers. As an ovarian cancer survivor, she describes the help provided by the recently launched “Steps Through Ovarian Cancer” program.
Ovarian Cancer
By Wayne Kuznar
The follow-up results of more than 5 years of the multicenter phase 3 SOLO2 clinical trial of women with ovarian cancer were presented at the 2020 ASCO annual meeting, showing improved survival with the use of Lynparza (olaparib) compared with placebo.
FDA Approvals, News & UpdatesOvarian Cancer
In April 2020, the FDA approved Zejula for long-term maintenance therapy for all patients with advanced ovarian cancer, regardless of any gene mutations.
Patient StoriesOvarian Cancer
By Gail Silver
Julie Silver ran into many “bumps in the road” after she was diagnosed with stage IV ovarian cancer. Despite many difficulties along the way, today her life is filled with gratitude and appreciation.
Ovarian Cancer
Late last year, the PARP inhibitor Zejula was approved by the FDA for patients with HRD mutation associated with advanced ovarian, fallopian tube, or primary peritoneal cancer, offering a new treatment option for women with these types of cancer.
Ovarian Cancer
There are a number of excellent organizations providing resources and support to you as a patient with ovarian cancer or a caregiver.
Ovarian Cancer
As a retired college professor, Dr. McElhiney uses her personal experience with ovarian cancer to advocate for other patients, urging faster development of new treatment options.